Axsome Therapeutics reports 66% Q4 revenue growth, blockbuster potential for Auvelity, and robust pipeline progress with 3 NDA filings and key ...

Link Mobility reported its Q4 2024 earnings, showcasing strong financial performance and strategic advancements. While the company did not provide specific earnings per share (EPS) or revenue data for ...